11:15

BREAK

11:30

Invited Discussion: Considerations for Shaping the Agenda

Moderator: Carlos Lopez, Research Fellow, Eli Lilly and Company

 

Olusoj Adeyi, Senior Health Specialist, World Bank

William Makgoba, President, Medical Research Council of South Africa (by teleconference)

Mark Miller, Associate Director for Research and Director, Division of International Epidemiology and Population Studies, Fogarty International Center, NIH

Ralph Timperi, Chair, APHL Global Health Committee and Assistant Commissioner/Director, State Laboratory Institute Massachusetts Department of Public Health

1:00

Lunch

Session IV: The Global Application of Tools, Technology, and Knowledge to Counter the Consequences of Infectious Diseases: A Discussion of Priorities and Options

2:00

With the backdrop of the two days’ presentations and discussion, Forum members, panel discussants, and the audience will comment on the issues and next steps that they would identify as priority areas for consideration within industry, academia, government agencies, public health organizations, and other nongovernmental organizations. The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the options and considerations for research, development, and capacity building. The complexities of interactionamong private industry, research and public health agencies, regulatory agencies, policymakers, academic researchers, and the public will be explored with an eye toward innovative responses to the challenges and opportunities presented by an increasingly “globalized” world.

Moderator: Adel Mahmoud, President, Merck Vaccines



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement